Real-world comparison: Neoadjuvant pembrolizumab (pembro-NACT) vs. dose-dense neoadjuvant chemotherapy (ddNACT) in early stage triple-negative breast cancer (TNBC). This is an ASCO Meeting Abstract ...
Monoclonal gammopathies represent a broad differential diagnosis and require a thorough evaluation for clinical significance. Smoldering multiple myeloma is a clinical entity that does not require ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results